April 19, 2017
Patient blood management is a patient-focused, evidence-based and systematic approach to improve patient outcomes through the safe and rational use of blood and blood products and avoiding unnecessary transfusions. European Commission has published two guides on Patient Blood Management, one addressed to health authorities and the other is a practical implementation guide for hospitals.
March 24, 2017
Rare Lives project wants to give the 30 million people living with a rare disease in Europe the visibility and strength, raising awareness and attention of the citizenship on rare diseases through the construction of a network which combines the experiences of those living the condition of rare patient and those who are not. Take a look on the journal!
March 15, 2017
After the kick off conference held last 9th and 10th March in Vilnius, a set of dissemination material (flyer, brochure and video) have been prepared by the European Commission with the aim of rising awareness on the meaning, objectives and expected outcomes of the 24 ERNs.
March 11, 2017
The first 24 ERNs approved last December were awarded in a two-day conference held 9th-10th March in Vilnius organized by the European Commission and the Maltese Presidency of the Council and hosted by the Ministry of Health of Lithuania with more than 600 participants. The ERNs cover 24 clinical areas and bring together more than 313 hospitals and almost 1000 healthcare units of expertise across 25 EU countries and Norway. One of the approved networks has been EuroBloodNet, the ERN on Rare Hematological Diseases, resulting from joint efforts of the European Hematology Asssociation (EHA), and ENERCA.
March 10, 2017
Orphanet was established in France by the INSERM (French National Institute for Health and Medical Research) in 1997 with the aim to provide high-quality information on rare diseases, and ensure equal access to knowledge for all stakeholders. Celebrating its 20th anniversary, Orphanet has enveiled its new website with an easier navigation and reading and searching options and responsive design. Check it out in www.orphanet.net !
April 29-30, 2017
Sickle cell disease (SCD) is a target condition of the national newborn screening (NBS) programs in only five countries (France, Greece, The Netherlands, Spain and UK). However, the importance of SCD screening is increasingly acknowledged as a global challenge all over Europe and various regional programs as well as pilot studies have been initiated during last years. This Conference aims to evaluate the current situation of SCD NBS in Europe and general and discuss the pertinence of the various screening strategies. For more information please go to Pan-European Consensus Conference on Newborn Screening for Haemoglobinopathies website
Organizing committee: Elena Cela, Madrid Raffaella Colombatti, Padua Jacques Elion, Paris Stephan Lobitz, Berlin
May 4-6, 2017
The objective of the course is to give opportunity to the attendees to have close contact and lively interaction with the teachers and the group in a nice setting. All slides will be available onsite. The speakers are chosen not only for their expertise in their subject but also for their teaching skills and willingness to discuss the field of transplant in both formal and informal settings. The course is suitable for physicians at all stages of their career and is particularly useful for those in training, for those who wish to develop their current practice to a more challenging type of transplant and also as an update for established transplanters. The program will include: • Plenary sessions • Clinical cases • Poster presentation • Breakfast meet the expert sessions • Meet the expert dinner
European School of Hematology and European Society for Blood and Marrow Transplantation.
June 22-25, 2017
The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance. Hematologists and affiliated professionals attending the EHA Congress will be able to: Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases. Access the latest results on clinical and translational research in hematologic disorders. Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties. Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.
European Hematology Association (EHA)
September 18-22, 2017
The International Summer school intend i) to promote the establishment of Findable, Accessible, Interoperable, Reusable (FAIR) registries in compliance with IRDiRC and EU Recommendations and ii) to support cooperation among different registry stakeholders and coordination with registries that are developed within European Reference Networks and National Plans in the EU.
Istituto Superiore di Sanità